DMARD, disease-modifying antirheumatic drug

Audit on the uptake of influenza and pneumococcal vaccination in patients with rheumatoid arthritis
John Pradeep, Richard Watts, Gavin Clunie

Annals of the Rheumatic Diseases Jun 2007, 66 (6) 837-838; DOI: 10.1136/ard.2006.060285
Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study
P L C M van Riel, A J Taggart, J Sany, M Gaubitz, H W Nab, R Pedersen, B Freundlich, D MacPeek

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1478-1483; DOI: 10.1136/ard.2005.043299
Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis
Helena Marzo-Ortega, Dennis McGonagle, Laura A Rhodes, Ai Lyn Tan, Philip G Conaghan, Philip O’Connor, Steven F Tanner, Alexander Fraser, Douglas Veale, Paul Emery

Annals of the Rheumatic Diseases Jun 2007, 66 (6) 778-781; DOI: 10.1136/ard.2006.063818
HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis
Pauline Y P C Ho, Anne Barton, Jane Worthington, Wendy Thomson, Alan J Silman, Ian N Bruce

Annals of the Rheumatic Diseases Jun 2007, 66 (6) 807-811; DOI: 10.1136/ard.2006.064972
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial
Gerd R Burmester, Xavier Mariette, Carlomaurizio Montecucco, Indalecio Monteagudo-Sáez, Michel Malaise, Athanasios G Tzioufas, Johannes W J Bijlsma, Kristina Unnebrink, Sonja Kary, Hartmut Kupper

Annals of the Rheumatic Diseases Jun 2007, 66 (6) 732-739; DOI: 10.1136/ard.2006.066761
Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab
E Filippucci, A Iagnocco, F Salaffi, A Cerioni, G Valesini, W Grassi

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1433-1437; DOI: 10.1136/ard.2005.044628
Comparing the long-term clinical outcome of treatment with methotrexate or sulfasalazine prescribed as the first disease-modifying antirheumatic drug in patients with inflammatory polyarthritis
S L Hider, A Silman, D Bunn, S Manning, D Symmons, M Lunt

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1449-1455; DOI: 10.1136/ard.2005.049775
Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis
M L E Andersson, I F Petersson, K E Karlsson, E N Jonsson, B Månsson, D Heinegård, T Saxne

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1490-1494; DOI: 10.1136/ard.2005.051292
Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis
M Vis, E A Havaardsholm, G Haugeberg, T Uhlig, A E Voskuyl, R J van de Stadt, B A C Dijkmans, A D Woolf, T K Kvien, W F Lems

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1495-1499; DOI: 10.1136/ard.2005.044198
Joint surgery in the Utrecht Rheumatoid Arthritis Cohort: the effect of treatment strategy
S M M Verstappen, J N Hoes, E J ter Borg, J W J Bijlsma, A A M Blaauw, G A van Albada-Kuipers, C van Booma-Frankfort, J W G Jacobs

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1506-1511; DOI: 10.1136/ard.2005.049957

Main menu

DMARD, disease-modifying antirheumatic drug

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

DMARD, disease-modifying antirheumatic drug

Pages